Jacksonville Business Development Grant
City of Jacksonville
About the Grant
The Commercial Development Authority (CDA) of the City of Jacksonville, Alabama, in its continuing effort to support the development of commercial business in Jacksonville, has created a Business Development Grant Program for business owners and tenants. The Business Development Grant Program will continue the process of creating an atmosphere conducive to conducting business in Jacksonville while attracting new commercial development. The following outlines the details of Jacksonville’s Business Development Grant Program. Business Development Grants are awarded by the CDA to encourage entrepreneurship, investment, and business success in the City of Jacksonville for new, expanding, and transitioning businesses. Grants are contingent on the availability of funding. Businesses must be located within the City of Jacksonville and meet the eligibility requirements.
Notes
Related Grants
Mesa Business Export Assistance Program
City of Mesa
The city of Mesa has a Business Export Assistance Program that reimburses qualified Mesa-based businesses for up to 50% of expenses related to starting or increasing international exports. To qualify, you need to be headquartered in Mesa and have no more than $25 million in annual sales.
SC Federal Matching Grant (formerly SBIR/STTR Phase I)
South Carolina Research Authority
Managed by the Academic Innovations Team, the objective of the Federal Matching Grant is further federal funds received by small businesses in South Carolina to advance translational research in support of one or more critical milestones towards commercialization. Preference given to SBIR/STTR awardees with initial datasets who identify gaps in commercialization activities that would help develop a compelling proposal for follow on funding. Other Federal matches will be considered on a case-by-case basis. Key milestones include developing the technology past the minimum viable product (MVP) and demonstrating product-market fit, in the DEVELOP stage of startup development. In the ACCELERATE stage of startup development, key milestones include enabling product execution through testing and demonstrations. Federal Matching Grants can match funds up to 50% of a qualifying federal award, not to exceed $50,000.
Skip Instant Grant
SKIP
Skip offers Instant Grants on a rolling basis, providing funding opportunities with shorter turnaround windows. These grant amounts are customized based on the number of Skip services you use. Grants are announced a couple of days in advance and generally occur twice a week, with deadlines on Tuesdays and Fridays. Applicants must participate in Skip’s YouTube livestream during the selection process.
Advanced Technologies and Instrumentation for the Astronomical Sciences
U.S. National Science Foundation
The Advanced Technologies and Instrumentation for the Astronomical Sciences (ATI) program provides individual investigator and collaborative research grants for the development of new technologies and instrumentation for use in ground-based astronomy and astrophysics.The program supports achieving the science objectives of the Division of Astronomical Sciences. The development of innovative, potentially transformative, technologies and instruments are sought, even at high technical risk.Supported categories include (but are not limited to):advanced technology development, concept feasibility studies, and specialized instrumentation to enable new observations that are difficult or impossible to obtain with existing means.Proposals may include hardware and/or software development and/or analysis to enable new types of astronomical observations.
Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids
National Institutes of Health
This notice of funding opportunity (NOFO) will support research towards understanding and mitigating the deleterious effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids (e.g., fentanyl, carfentanil, nitazenes) and their combinations (fentanyl and xylazine). This NOFO will also support research on the persistent and/or delayed pathophysiological effects after acute exposure to such agents.